The World Health Organisation (WHO) has published guidance in relation to administration of vinca alkaloids via intravenous minibag infusion to avoid accidental death

Our previous guidance document on this subject, produced in 2008 and revised in 2010 has now been withdrawn.

We refer you to the National Cancer Control Programme (NCCP) Guidance on the Safe Use of Neurotoxic drugs (including Vinca Alkaloids) in the Treatment of Cancer (November 2015)